Abel GA[au] - Search Results

Year	Number of Results
1999	1
2002	2
2004	1
2005	2
2006	1
2007	1
2008	5
2009	2
2010	3
2011	5
2012	13
2013	29
2014	24
2015	23
2016	30
2017	18
2018	24
2019	29
2020	18
2021	24
2022	2

1

Frailty and the management of hematologic malignancies.

Abel GA, Klepin HD. Abel GA, et al. Blood. 2018 Feb 1;131(5):515-524. doi: 10.1182/blood-2017-09-746420. Epub 2017 Nov 15. Blood. 2018. PMID: 29141942 Free article. Review.

2

Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study.

Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, Lyratzopoulos G. Koo MM, et al. Among authors: abel ga. Lancet Oncol. 2020 Jan;21(1):73-79. doi: 10.1016/S1470-2045(19)30595-9. Epub 2019 Nov 6. Lancet Oncol. 2020. PMID: 31704137 Free PMC article.

3

Pentito.

Abel GA. Abel GA. JAMA Oncol. 2019 Apr 1;5(4):580. doi: 10.1001/jamaoncol.2018.6869. JAMA Oncol. 2019. PMID: 30763415 No abstract available.

4

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. Zhou Z, et al. Among authors: abel ga. Blood. 2014 Feb 6;123(6):837-42. doi: 10.1182/blood-2013-09-524108. Epub 2013 Nov 21. Blood. 2014. PMID: 24264230 Free PMC article.

5

Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis.

Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Koo MM, et al. Among authors: abel ga. Cancer Epidemiol. 2017 Jun;48:140-146. doi: 10.1016/j.canep.2017.04.010. Epub 2017 May 23. Cancer Epidemiol. 2017. PMID: 28549339 Free PMC article.

6

The Best Medicine.

Abel GA. Abel GA. JAMA Oncol. 2019 Mar 1;5(3):350. doi: 10.1001/jamaoncol.2018.6689. JAMA Oncol. 2019. PMID: 30703207 No abstract available.

7

Management of older adults with myelodysplastic syndromes (MDS).

Luskin MR, Abel GA. Luskin MR, et al. Among authors: abel ga. J Geriatr Oncol. 2018 Jul;9(4):302-307. doi: 10.1016/j.jgo.2017.12.002. Epub 2017 Dec 29. J Geriatr Oncol. 2018. PMID: 29290596 Review.

8

Assessing Quality of Care for the Myelodysplastic Syndromes.

Frosch ZA, Abel GA. Frosch ZA, et al. Among authors: abel ga. Curr Hematol Malig Rep. 2016 Dec;11(6):402-407. doi: 10.1007/s11899-016-0343-0. Curr Hematol Malig Rep. 2016. PMID: 27562670 Review.

9

Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review.

DuMontier C, Loh KP, Bain PA, Silliman RA, Hshieh T, Abel GA, Djulbegovic B, Driver JA, Dale W. DuMontier C, et al. Among authors: abel ga. J Clin Oncol. 2020 Aug 1;38(22):2558-2569. doi: 10.1200/JCO.19.02809. Epub 2020 Apr 6. J Clin Oncol. 2020. PMID: 32250717 Free PMC article. Review.

10

Assessing patients at risk of symptomatic-but-as-yet-undiagnosed cancer in primary care using information from patient records.

Lyratzopoulos G, Abel GA. Lyratzopoulos G, et al. Among authors: abel ga. Br J Cancer. 2020 Jun;122(12):1729-1731. doi: 10.1038/s41416-020-0828-4. Epub 2020 Apr 15. Br J Cancer. 2020. PMID: 32291393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results